Education
About Us
Working with TipRanks
Follow Us
IRLAB Therapeutics AB Class A (DE:6IRA)
BERLIN:6IRA
Earnings Data
Report Date
Feb 11, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
>-0.01Same Quarter Last Year
Moderate Sell
Based on 0 Analysts Ratings
DE:6IRA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:6IRA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | €0.21 | €0.22 | +4.76% |
Aug 27, 2025 | €0.28 | €0.28 | 0.00% |
May 07, 2025 | €0.59 | €0.65 | +10.17% |
Feb 12, 2025 | €1.14 | €1.08 | -5.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does IRLAB Therapeutics AB Class A (DE:6IRA) report earnings?
IRLAB Therapeutics AB Class A (DE:6IRA) is schdueled to report earning on Feb 11, 2026, TBA (Confirmed).
What is IRLAB Therapeutics AB Class A (DE:6IRA) earnings time?
IRLAB Therapeutics AB Class A (DE:6IRA) earnings time is at Feb 11, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of IRLAB Therapeutics AB Class A stock?
The P/E ratio of IRLAB Therapeutics AB Class A is N/A.
What is DE:6IRA EPS forecast?
Currently, no data Available